Our Entrepreneurs-in-Residence

Blackstone Entrepreneurs-in-Residence (EIRs) work one-on-one and as a team with area startups. These 15 EIRs have collectively founded 46 companies, employed over 5000 employees, raised over $1 Billion for companies they founded and another $4.2 billion for non-founded companies, with total exit values of $10.2 billion and counting; 6 were IPOs.

Blackstone EIRs also work with our companies in a team setting to provide feedback and guidance on business development, marketing, and financial strategy, and to identify potential funding opportunities within their network. EIRs are known for their experience, neutrality, collaboration, and impact in the community. They have served on over 70 boards for local companies and organizations in the RT Region and more than a dozen national or international boards.

Peyton Anderson

CEO - Affinergy, Biomedical Entrepreneur, Board Advisor

Peyton Anderson is a serial entrepreneur who co-founded SciQuest, Inc. in 1995 as its founding CEO. SciQuest raised over $175 million in capital, including a successful Initial Public Offering in 1999. His responsibilities included raising capital, recruiting the management team, doing strategic partner deals, and orchestrating 8 acquisitions. SciQuest continues to thrive and currently has...

Peyton Anderson is a serial entrepreneur who co-founded SciQuest, Inc. in 1995 as its founding CEO. SciQuest raised over $175 million in capital, including a successful Initial Public Offering in 1999. His responsibilities included raising capital, recruiting the management team, doing strategic partner deals, and orchestrating 8 acquisitions. SciQuest continues to thrive and currently has greater than 500 employees.

Peyton co-founded Affinergy in September 2003 where he remains the CEO.  The 28 person company is developing diagnostic products and research tools in the orthopedic and soft tissue repair markets.  Since 2003, Affinergy has secured $50m+ from a combination of investor and non-dilutive sources.

Peyton currently serves as Chair of the NC Biosciences Organization and is on the Board of Directors of The North Carolina Biotechnology Center and Quantifize.  Previously, he served on the executive committee of the Board of Directors for the Council for Entrepreneurial Development.

Peyton enjoys helping entrepreneurial founders develop business plans, recruit senior advisors, and navigate the startup financing process to secure grants, angel funding, strategic partnering deals and venture capital.  He is also a frequent speaker at entrepreneurial conferences and MBA classes.  He graduated Phi Beta Kappa from the University of Richmond in 1989 and earned his MBA from UNC’s Kenan Flagler Business School in 1995.

More

Peter Bourne

CEO, BrightWolf; Board Member; Strategic Growth Advisor

Peter Bourne has leadership achievements spanning all company operations including P&L, sales and marketing, and R&D. He has spent 15 years in CEO, COO, EVP and GM roles at both public and private companies, from early stage through revenue to profitability and exits generating in aggregate over $2 billion. Peter’s key strengths include establishing successful company strategies,...

Peter Bourne has leadership achievements spanning all company operations including P&L, sales and marketing, and R&D. He has spent 15 years in CEO, COO, EVP and GM roles at both public and private companies, from early stage through revenue to profitability and exits generating in aggregate over $2 billion. Peter’s key strengths include establishing successful company strategies, building and re-sizing organizations, and motivating teams. He possesses M&A experience as both target and acquirer from initial contact through final integration, including complex and international transactions.
Peter currently serves on several boards, and is involved in both advisory and operational roles with many local companies. Peter is most productive solving problems related to scaling products in to markets, translating vision into actionable strategy, and structuring and motivating teams to exceed their goals.

More

Kevin Bowles

CEO - Hesiod & Associates; strategic advisor

Kevin Bowles has over 25 years of experience and success with entrepreneurial ventures, both nationally and internationally, in roles as a CEO, VC, Consultant/Advisor and Educator. He has proven the ability to craft a vision, develop a business plan, raise the capital, form the team and lead, with passion, the execution of the business model. Kevin has achieved this model several times in a...

Kevin Bowles has over 25 years of experience and success with entrepreneurial ventures, both nationally and internationally, in roles as a CEO, VC, Consultant/Advisor and Educator. He has proven the ability to craft a vision, develop a business plan, raise the capital, form the team and lead, with passion, the execution of the business model. Kevin has achieved this model several times in a variety of sectors including: technology, clean tech, energy, media, medical device, consumer products and education technology resulting in two private financial exits.

Kevin currently sits on the Advisory Board of Lonerider Beer, a top 5 Craft Beer Company in North Carolina where he is advising Lonerider on a growth strategy through partnerships as well as capital formation. Kevin also recently lead the sale of an energy technology company for $8MM to a Canadian-based energy company, and a Danish medical device company to a US-based medical device company for over $1MM in cash and royalties. He is CEO/Founder of Box Lunch Media which sells nature based media to the education/national parks market on a direct basis and through Discovery Education.

Kevin previously served in a variety of executive and operating roles. He was Director of corporate strategic planning for Blue Cross and Blue Shield of North Carolina; a venture capitalist at Cherokee Investments/Fairview Advisors; associate at Scott Madden; and an exploration geophysicist and a natural gas and gas storage marketer for Texaco USA (now Chevron).

Kevin earned an MBA from UNC Kenan-Flagler, a MS in Geology from Louisiana State University and a BS in Geology from Washington and Lee University.

More

Lee Buck

Founder - Blue Bright Ventures LLC

Buck is the founder of Blue Bright Ventures LLC, which invests in early stage technology companies in the Southeast. He is also a Partner in LaunchBox Digital, an early stage technology accelerator, and a mentor and advisor to area entrepreneurs. Prior to his investment activities, Buck built a succession of software companies that anticipated and benefited from successive waves of...

Buck is the founder of Blue Bright Ventures LLC, which invests in early stage technology companies in the Southeast. He is also a Partner in LaunchBox Digital, an early stage technology accelerator, and a mentor and advisor to area entrepreneurs.

Prior to his investment activities, Buck built a succession of software companies that anticipated and benefited from successive waves of technology disruption.

Most recently, Buck was the co-founder and Chief Technology Office of Near-Time. Near-Time enables organizations to leverage web 2.0 technologies to build more dynamic interactive relationships with customers, partners and other stakeholders.

Previously, Buck was the co-founder and CTO of Extensibility, Inc. a leading provider of XML solutions, acquired by TIBCO Software, Inc. After the acquisition Buck served as TIBCO’s VP & Chief Scientist, XML Technologies. Buck is a recognized authority on XML and schema and has helped shape a number of Internet standards by serving on committees such as the W3C’s XML Schema Working Group.

Prior to Extensibility, Buck founded Software Designs Unlimited helping clients such as National Geographic Society, Simon & Schuster and McGraw Hill to bring educational and informational resources to computers via CD-ROMs. Buck was also an award winning author of an AppleScript Rapid Application Development tool bundled by Apple Computer.

More

Jan Davis

Active board member and advisor

Jan Davis is an active board member and advisor of companies in software, analytics, direct and interactive marketing, and personal information. In addition to her role as Entrepreneur in Residence for the Blackstone Entrepreneurs Network, she serves on the Investment Committee of The Launch Place Seed Fund and for the Minor in Entrepreneurship in the College of Arts & Sciences at the...

Jan Davis is an active board member and advisor of companies in software, analytics, direct and interactive marketing, and personal information. In addition to her role as Entrepreneur in Residence for the Blackstone Entrepreneurs Network, she serves on the Investment Committee of The Launch Place Seed Fund and for the Minor in Entrepreneurship in the College of Arts & Sciences at the University of North Carolina at Chapel Hill. She is an investor in Triangle Angel Partners and is the immediate past President of its Executive Committee. She serves on the boards of directors of SEAL Innovation, Stealz and ShowingTime.com, where she chairs the Audit Committee, and on the boards of advisors for multiple companies, including AlphaRank, Megalytics, Market Vue Partners, Spring Engage and Three Ships. These enterprises sell products and services to the retail, real estate, marketing services, and information industries as well as to consumers.

As CEO of ShopperTrak RCT Corporation, the global leader in pedestrian traffic counting, from 2004 to 2008, Jan led the company to profitability. Revenues doubled, and the number of managed counting devices increased by 136%. ShopperTrak also expanded its international footprint significantly, including forming a wholly-foreign-owned subsidiary in China. Today, the company monitors counting devices in retail stores, malls and casinos in 65 countries and was recently acquired by Tyco.

Before joining ShopperTrak, Jan spent more than 15 years in direct and interactive marketing, including eight years with TransUnion LLC, the international credit reporting giant. She led TransUnion’s online consumer division as president, overseeing the acquisition and integration of TrueLink, an early-stage company with products in the interactive, direct-to-consumer space. Previously, she oversaw TransUnion’s PerformanceData and Insurance divisions, providing marketing data to a broad range of direct marketing companies and marketing lists, scoring models and underwriting data to the property and casualty insurance industry.

From 1991 to 1996, Jan was a marketing consultant in Boston, MA and Warsaw, Poland, working with US, multi-national and Polish enterprises. During this period she served for two years as vice president/new ventures for Customer Development Corporation, a database marketing agency.

In the late 1980s, she co-founded SmartNames, a database marketing information, analysis and services company. In that role, she participated in raising $15 million in venture capital and acquiring four other companies.

Ms. Davis has served on the boards of directors of GSP Retail, Truelink, RCT Analytics Ltd., ShopperTrak, the Illinois Technology Association, and the Chicago Finance Exchange and on the Alumni Council at UNC Kenan-Flagler Business School. She’s served on the advisory boards of RetelTechnologies (purchased by ShopperTrak), GeeYee and Ribstone. She holds BA and MBA degrees from the University of North Carolina at Chapel Hill and relocated from the Chicago area to Cary NC in 2010.

More

Chris Evans

Entrepreneur, Board Member and Philanthropist

Chris Evans is an entrepreneur and philanthropist with offices in Raleigh, North Carolina. Chris currently serves as the Executive Chair of Tethis, a Raleigh-based Biomaterials company. Chris served as CEO and founder of Accipiter, a leading provider of ad management solutions (purchased by CMGI, Inc. and fully merged with Engage in 1998), and member of the Board of Directors for Engage (NASD:...

Chris Evans is an entrepreneur and philanthropist with offices in Raleigh, North Carolina. Chris currently serves as the Executive Chair of Tethis, a Raleigh-based Biomaterials company. Chris served as CEO and founder of Accipiter, a leading provider of ad management solutions (purchased by CMGI, Inc. and fully merged with Engage in 1998), and member of the Board of Directors for Engage (NASD: ENGA) a majority owned subsidiary of CMGI, a provider of profile driven Internet marketing solutions from 1999 until 2001. In 1992, Evans founded Hotlinx, a publisher of print and online buyer’s guides for software professionals, which was sold to a group of private investors in 1997. From 1985 through 1992, Chris co-founded and served as the executive Vice President of DaVinci Systems, which developed the first E-mail application for the Microsoft Windows platform. The company was acquired by On Technology.
Chris currently serves on the board of directors of Community in Schools of Wake County, NC State’s Entrepreneurs Initiative Advisory Board, and DOOR International. He also serves as an advisor to several businesses and not-for-profit enterprises in the US and Europe. Evans is also the author of Fruit at Work – Mixing Christian Virtues with Business published in 2012 by Lanphier Press.
Chris’ many accolades include the 1999 Ernst & Young “Master Entrepreneur” award; Business Leader Magazine’s “Entrepreneur of the Year” in 1998, the 1998 North Carolina Council for Entrepreneurial Development “Entrepreneurial Excellence Award”, and was named one of Advertising Age’s Digital Media Masters.

More

Kip Frey

Entrepreneur, Venture Capitalist, Educator

Kip Frey is an entrepreneur, venture capitalist, and educator. He has served as CEO of several start-up companies, and as a partner at venture capital firm Intersouth Partners. He is currently President and CEO of Canines, Inc., an early-stage company focused on animal cognition, which he founded with Duke anthropology professor Brian Hare. He has also held senior positions on the management...

Kip Frey is an entrepreneur, venture capitalist, and educator. He has served as CEO of several start-up companies, and as a partner at venture capital firm Intersouth Partners. He is currently President and CEO of Canines, Inc., an early-stage company focused on animal cognition, which he founded with Duke anthropology professor Brian Hare. He has also held senior positions on the management teams and boards of companies leveraging media and intellectual property.

Prior to joining Intersouth as a venture capitalist in 2000, Frey ran several venture-backed companies. From 1994 to 1998 he served as Executive Vice President and General Counsel of Ventana Communications Group, having sold the company in 1994 to Thomson Corporation. In 1998 he became President of Accipiter, Inc. and sold the company to CMGI, Inc., structuring the transaction so that its ultimate value exceeded $500 million.

Later that year Frey became President and CEO of OpenSite Technologies, Inc., which was acquired in 2000 by Siebel Systems for $542 million. OpenSite was named NCEITA Software Company of the Year in 1999 and Frey was honored by Digital South Magazine as the Southeast’s top entrepreneurial CEO. He received the Council for Entrepreneurial Development’s Entrepreneurial Excellence Award in 2000.

Frey is a lawyer by training and practiced intellectual property law for five years before joining Turner Broadcasting System in 1990. While at Turner he ran several business units and contributed to the acquisition of Castle Rock Entertainment, the formation of the Cartoon Network, and the construction of the MGM Grand Hotel and Casino.

Frey has taught classes at Duke University since 1994 and has held appointments as Professor of the Practice at Sanford School of Public Policy, Duke Law School and the Fuqua School of Business.  As Director of the Law & Entrepreneurship Program at Duke Law School, Frey teaches entrepreneurial management, intellectual property law and policy.  Starting June 2017, he will be the director for the Innovation & Entrepreneurship Initiative.

He currently serves on the boards of several private companies and one publicly-traded company, Inspire Pharmaceuticals Inc.

More

Don Holzworth

Public Health Entrepreneur, Board Chair, Philanthropist

Don Holzworth is Executive in Residence at Blackstone Entrepreneurs Network and the University of North Carolina (UNC) Gillings School of Global Public Health. He is Chairman of the School’s Advisory Council, and an Adjunct Professor of Health Policy and Management. He is the former Founder, Chairman, and Chief Executive Officer of Constella Group, a leading global provider of public health...

Don Holzworth is Executive in Residence at Blackstone Entrepreneurs Network and the University of North Carolina (UNC) Gillings School of Global Public Health. He is Chairman of the School’s Advisory Council, and an Adjunct Professor of Health Policy and Management.
He is the former Founder, Chairman, and Chief Executive Officer of Constella Group, a leading global provider of public health policy and implementation services operating in more than 60 countries before being sold to SRA International in 2007. He was also the founder and served as chairman of the board of Expression Analysis, Inc., a genomic services company spun out of Duke University Medical Center and sold to Quintiles in 2012.
In 2011 he co-founded and now serves on the board of Veritas Collaborative, a specialty behavioral hospital serving adolescents and adults with severe eating disorders. He currently fulfills the role of Executive Chairman for Bivarus, Inc. a patient centered analytics company co-founded by a UNC and Duke physician and as Chairman for Health Decisions, Inc. a specialty CRO using data-driven insight and agility to deliver clinical development services.
Since 2006 he has served as a member of the Board of the Accordia Global Health Foundation, which is creating a network of Centers of Excellence to drive health innovation in Sub-Saharan Africa. He is also the founder of Giving Positively, a non-profit organization providing vocational scholarships to HIV positive young adults in Kampala, Uganda.
Holzworth is Executive Chairman of Health Decisions and Bivarus, and also serves as an advisory board member for the Frank Hawkins Kenan Institute for Private Enterprise, and is an advisor to Southern Capitol Ventures and Bull City Venture Partners.
In 2003 and again in 2007, he was recognized by the North Carolina Council for Entrepreneurial Development with its Entrepreneurial Excellence Award. In 2005, Ernst & Young named him as a Carolinas Entrepreneur of the Year® and he subsequently served as both a regional and national judge for this prestigious program.
His public health experience led to a 2008 appointment to the Presidential Advisory Council on HIV/AIDS.

More

Igor Jablokov

Entrepreneur, Board Member, Thought Leader in AI and CyberSecurity

Igor Jablokov was founder and CEO of Yap, an institutionally-funded venture that pioneered cloud-based speech recognition. Its technology was deployed by numerous customers, including Microsoft and Sprint, and received accolades for their innovations, including being named North Carolina’s Early Stage Company of the Year and as a finalist at the first ever TechCrunch Disrupt conference. The...

Igor Jablokov was founder and CEO of Yap, an institutionally-funded venture that pioneered cloud-based speech recognition. Its technology was deployed by numerous customers, including Microsoft and Sprint, and received accolades for their innovations, including being named North Carolina’s Early Stage Company of the Year and as a finalist at the first ever TechCrunch Disrupt conference. The startup was subsequently acquired by Amazon and is integrated into successful products such as the Alexa Voice Service platform, the Echo speaker, and the Fire TV set top box.

To support his role as a Blackstone EIR, Igor serves on the board for the Council for Entrepreneurial Development and as a Venture Partner at Rubicon Venture Capital. Igor also advises Penn State’s College of Engineering and the World Economic Forum’s Global Shapers. He was awarded Eisenhower and Truman National Security Fellowships to deepen collaboration between government and industry.

Prior to founding Yap, Igor was Program Director of IBM Software Group’s multi-modality initiatives, leading a worldwide team that created the first speech-enabled Web browser. Additionally, he was a mentor for IBM’s Extreme Blue internship program and Chairman of the VoiceXML Forum, an industry group championing a standards-based vision of speech computing. Igor previously held positions with IBM’s Pervasive Computing, PartnerWorld, Global Industries and MicroElectronics divisions.

With over a dozen patents granted and pending, he was named an industry luminary by Speech Technology magazine and an outstanding engineering alumnus of Penn State. Igor holds an undergraduate degree in computer engineering from The Pennsylvania State University and an MBA from The University of North Carolina.

More

Tim Huntley

CEO - PERSONALIZED LEARNING GAMES

Tim Huntley is the CEO of Personalized Learning Games, a 2015 EdTech spinout of 3C institute, focused on helping K-12 students improve their social and emotional skills.  He is the former CEO of Ganymede Software, a venture-backed start-up he founded in 1995 with three friends from IBM.  Ganymede developed two award winning products, Chariot and Pegasus, for testing and measuring the...

Tim Huntley is the CEO of Personalized Learning Games, a 2015 EdTech spinout of 3C institute, focused on helping K-12 students improve their social and emotional skills.  He is the former CEO of Ganymede Software, a venture-backed start-up he founded in 1995 with three friends from IBM.  Ganymede developed two award winning products, Chariot and Pegasus, for testing and measuring the performance of applications running over enterprise computer networks.  The company grew from four people to one hundred, raised $10 million in equity capital, and had twelve month trailing revenues of $13 million before being acquired in 2000 by Mission Critical/NetIQ for $170 million.

Following Ganymede’s acquisition by NetIQ, Mr. Huntley was involved in a wide range of M&A, due diligence, and investment activities. These included the integration of WebTrends, the purchases of Marshal Software and SQL Probe from Subquery Innovations, and investments in @Stake and Lumigent Technologies.

Huntley is an active angel investor in the Raleigh-Durham community serving on the boards of Adzerk and Spring Engage, and enjoys spending time with his wife, Jenny, and their twin boys, Neil and Evan.  He graduated in 1989 from North Carolina State University with a BS in Computer Science.

More

Dr. Moise Khayrallah

Drug Development Entrepreneur, Board Chair, Philanthropist

Dr. Khayrallah has been involved in drug development for 28 years in executive as well as research and development positions. He acquired his experience in diverse pharmaceutical environments including large pharmaceutical, contract research, and biotechnology companies. He is presently CEO and co-Founder of Aerial BioPharma, LLC, a biopharmaceutical holding company focused on developing drugs...

Dr. Khayrallah has been involved in drug development for 28 years in executive as well as research and development positions. He acquired his experience in diverse pharmaceutical environments including large pharmaceutical, contract research, and biotechnology companies. He is presently CEO and co-Founder of Aerial BioPharma, LLC, a biopharmaceutical holding company focused on developing drugs for treating several central nervous system disorders. In 2010, Dr. Khayrallah was co-founder, President and CEO of Neuronex Inc, a company focused on developing treatments for patients with certain seizure disorders. Neuronex was acquired by Acorda Therapeutics in late 2012. In 2006, he co-founded and served as President and CEO of Addrenex Pharmaceuticals, Inc., a specialty pharmaceuticals company that developed and received FDA approvals for compounds targeting the adrenergic system. Addrenex was acquired in late 2009 by Shionogi & Co. of Japan. In 2002, Dr. Khayrallah founded a consulting company, Alius Pharma, LLC, to partner with small biotechnology companies in cancer drug development. From 1999 to 2002, he was VP of Clinical Affairs at Cytran, Inc., a Seattle area biotechnology company, where he led the product development team for the company’s lead compound in cancer and participated in financing and joint venture activities. Prior to that, Dr. Khayrallah served as Director, Clinical Research and Regulatory Affairs at Lineberry Research Associates (later Constella Group and SRI International) in RTP, NC. While at Lineberry, he led project teams in implementing clinical projects and providing strategic consulting in several therapeutic areas. Dr. Khayrallah also served in various positions at Burroughs Wellcome and later Glaxo Wellcome from 1987 to 1996, where he led clinical programs and trials resulting in FDA approvals in CNS indications. He holds a Ph.D. degree in psychology from the University of North Carolina at Chapel Hill.

More

Richard West

CEO - BAEBIES

Rich West is currently co-founder and CEO of his fourth life sciences startup, which is focused on newborn screening [www.baebies.com]. Baebies, a revenue stage company, is bringing new technology, new tests, and new hope to kids and parents across the globe. Prior to Baebies, Rich and his team developed and then sold Advanced Liquid Logic to Illumina for $96M. Advanced Liquid Logic was a Duke...

Rich West is currently co-founder and CEO of his fourth life sciences startup, which is focused on newborn screening [www.baebies.com]. Baebies, a revenue stage company, is bringing new technology, new tests, and new hope to kids and parents across the globe. Prior to Baebies, Rich and his team developed and then sold Advanced Liquid Logic to Illumina for $96M. Advanced Liquid Logic was a Duke spinout that developed lab-on-a-chip technology and products for the research tools and diagnostic markets. Prior to Advanced Liquid Logic Rich was founder and CEO of TriVirix, a venture-funded medical equipment contract manufacturer that he and his team grew to over 500 employees.

Rich also spent fifteen years in the aerospace industry in program, sales, marketing, and engineering management, including four years as a commissioned officer in the US Air Force. Rich has an engineering degree from Duke University, an MBA from the University of West Florida and completed all requirements except dissertation for a PhD in management from the Peter F. Drucker Graduate School of Management. Rich is currently Chair of the Board for the Council for Entrepreneurial Development, is a board member of NCIdea and Nirvana Sciences, and is past Board Chairman for Triangle Residential Options for Substance Abuse, a non-profit that serves recovering substance abusers. Rich is also an adjunct professor at Duke University and teaches a course in entrepreneurship.

More

Kay Wagoner

President - Wagoner Discovery & Development LLC

Dr. P. Kay Wagoner Appointed University Life Science Entrepreneur-in-Residence The Office of the Vice Chancellor for Innovation, Entrepreneurship and Economic Development (IEED), is pleased to announce the appointment of Kay Wagoner, PhD as University life science entrepreneur-in-residence (EIR). Her leadership and innovation in healthcare, drug discovery and drug development have already made...

Dr. P. Kay Wagoner Appointed University Life Science Entrepreneur-in-Residence

The Office of the Vice Chancellor for Innovation, Entrepreneurship and Economic Development (IEED), is pleased to announce the appointment of Kay Wagoner, PhD as University life science entrepreneur-in-residence (EIR). Her leadership and innovation in healthcare, drug discovery and drug development have already made significant contributions to technologies emerging at UNC, and those contributions will be furthered in this new role.

As an EIR, Wagoner focuses on working with faculty to develop their discoveries and determine the best potential pathways to market.

“I have been extremely impressed with the quality and quantity of entrepreneurial life science opportunities evolving from prominent laboratories at UNC. I have had the good fortune of working with investigators who are developing innovative drugs, drug delivery technologies, devices and diagnostic tools,” says Dr. Wagoner. “The spirit of creativity and the desire to translate innovative discoveries into products is alive and well here at UNC, and I am excited to be a part of this revolution on behalf of IEED.”

As a successful entrepreneur and loyal alumna of Carolina, Wagoner has dedicated the past several years to fostering startups through her work as a Blackstone Entrepreneur-in-Resident, as an advisor with KickStart Venture Services, and as Executive Entrepreneur-in-Residence for the Eshelman School of Pharmacy.

“We are grateful for Dr. Wagoner’s commitment to serve as University life science EIR,” says Dhiren Thakker, Associate Dean for Entrepreneurial Development in UNC’s Eshelman School of Pharmacy. “With more than 25 years in the pharmaceutical/biotech industry, and with her experience in launching and leading a successful biotech company in RTP, she brings real-world knowledge and firsthand experiences that are valued enormously by the faculty entrepreneurs and entrepreneurial teams she supports.”

Wagoner serves as Adjunct Associate Professor in the UNC School of Medicine’s Department of Cell and Molecular Physiology and is President of Wagoner Discovery and Development. She also serves as Executive Chairman of the Duke spinout Valanbio Therapeutics Inc. – which is developing new antibiotics, and as an advisor and board member for UNC spinout Symberix Inc., which is focused on the GI microbiome.

“Dr. Wagoner’s proven experience collaboratively working with students, faculty and staff will underpin and carry forth our mission to strengthen UNC’s innovation ecosystem,” says Judith Cone, Vice Chancellor for Innovation, Entrepreneurship and Economic Development. “It is an honor to have her join us as an EIR, and we look forward to the great things she will accomplish in this role.”

Early in her career, Wagoner founded and served as President and CEO of Icagen Inc., a biopharmaceutical company in RTP. In her time there, she negotiated licenses to technologies from more than two dozen major universities and also negotiated and led multi-million dollar strategic alliances with six major pharmaceutical companies. She took venture-backed Icagen public on the Nasdaq in 2005 and in 2011, led its acquisition by Pfizer Inc.

Prior to Icagen, Wagoner founded a nonprofit cardiovascular company that delivered a broad array of cardiovascular preventive and rehabilitation services. Today, this services company forms a valuable part of the UNC Wellness Center complex. Additionally, following her postgraduate research work in physiology and pharmacology, Wagoner held research management positions at Glaxo, where she initiated and led Glaxo’s U.S. ion channel drug discovery efforts in central nervous system, cardiovascular and metabolic diseases.

As a leader in health care, university education, drug discovery and drug development, Wagoner has been honored by her peers in the industry. In 2001, she received the Distinguished Alumna Award for Science and Business from UNC Chapel-Hill. In 2004, she was awarded the Entrepreneurial Excellence Award by RTP-based CED and also the Ernst & Young Entrepreneur of the Year Regional Award for Life Sciences and Healthcare. In 2007, she was honored by the Women in Bio organization for outstanding achievement.

Wagoner also enjoys giving back to the community and has served on a variety of private, public and nonprofit boards of directors, including the N.C Biotechnology Center Board, the Biotechnology Industry Organization’s Emerging Companies Board, the UNC Eshelman School of Pharmacy Board of Visitors and the UNC School of Nursing Foundation Board.

She holds a master’s degree in nursing, is a Certified Clinical Nurse Specialist in Cardiovascular Disease and holds a Ph.D. in physiology from UNC. Her clinical practice spanned multiple hospital and out-patient healthcare delivery settings, and additionally she served on the UNC Chapel-Hill faculty in the School of Nursing.

To learn more about the Office of the Vice Chancellor for Innovation, Entrepreneurship and Economic Development visit oced.unc.edu or contact Michael Kline, Director of Engagement and Technology Development.

More

F. Scott Moody

BLACKSTONE EIR EMERITUS; CHAIRMAN AND CEO - K4 CONNECT

Scott Moody served as an active Entrepreneur-in-Residence with the Blackstone Entrepreneur Network from February 2013 until October 2015. He is presently co-founder and Chairman/CEO of K4Connect, providing a differentiated software platform that integrates disparate smart devices & systems into a responsive system for senior adults and those living with disabilities. Scott has raised over $2M in...

Scott Moody served as an active Entrepreneur-in-Residence with the Blackstone Entrepreneur Network from February 2013 until October 2015. He is presently co-founder and Chairman/CEO of K4Connect, providing a differentiated software platform that integrates disparate smart devices & systems into a responsive system for senior adults and those living with disabilities. Scott has raised over $2M in venture capital for this startup, including such investors as Better Ventures, Lowe’s Home Improvement, Sierra Ventures and Stonehenge Growth Equity.

Prior to serving as a Blackstone EIR, Scott was co-founder and former Chairman/CEO of AuthenTec, a leading provider of security and identity management solutions, acquired by Apple in October, 2012. The AuthenTec fingerprint sensor is now the foundation of the iPhone’s and iPad’s Touch ID. Authentec raised over $70 million in venture capital (including such investors as Sierra Ventures, The Carlyle Group, Texas Instruments, Stonehenge Growth Capital, China Development Industrial Bank and others). Scott led the company’s successful IPO in 2007 (NASDAQ) and recruited an excellent management team. He helped grow the company from the two co-founders to over 300 employees with development centers in Melbourne, Fl., Shanghai, China and Vught, The Netherlands.

Prior to founding AuthenTec, Scott was the Vice President of a $200 million division of Harris’ Semiconductor Sector (now Intersil) where he started as a newly graduated engineer in 1980. He led successful turnarounds of several diverse operations including the commodity logic business (sold to TI), the acquisition GE Microelectronics and turnaround of the Group’s Mil/Aero business.

Scott is the founder of First Talent Ventures which focuses on advising, mentoring and investing in early stage startups in the Southeast, while concurrently acting as an operating partner to venture capital firms sourcing opportunities in the region. First Talent Ventures also provides mentoring and investment support to entrepreneurs in Africa, with a particular focus on Rwanda where Scott has traveled previously as part of Christian mission trips.

Scott has been featured on TV and in publications such as the Wall Street Journal, Bloomberg, CNBC Squawk Box, Entrepreneur, New York Times, Fortune and others. He is a frequent speaker at investor, corporate and university events on both innovation and entrepreneurship, and is often a judge at various startup programs in the US and Rwanda.

Scott received a BS in Industrial Engineering from North Carolina State University in 1980 and an executive MBA from the University of Florida in 1987. He has served as an advisor to the Director, NSF Nanosystems Engineering Research Center at NC State University since November 2013.

More

Frank Plastina

BLACKSTONE EIR EMERITUS; CEO, WOLFSPEED

Frank Plastina recently served as an Entrepreneur-in-Residence with the Blackstone Entrepreneur Network from May 2012 – June 2015. He is currently the CEO of Wolfspeed - formerly Cree's Power and RF division - to structure the spinout and sale of Wolfspeed to Infineon Technologies. Mr. Plastina has served as the CEO of two NASDAQ listed companies and prior to this current role, he was the...

Frank Plastina recently served as an Entrepreneur-in-Residence with the Blackstone Entrepreneur Network from May 2012 – June 2015. He is currently the CEO of Wolfspeed – formerly Cree’s Power and RF division – to structure the spinout and sale of Wolfspeed to Infineon Technologies. Mr. Plastina has served as the CEO of two NASDAQ listed companies and prior to this current role, he was the Founder and President of Arc&Company. Arc&Company is an angel investment firm and also provides advisory services to “C” level executives.

Prior to serving as an EIR, Frank served as the President and CEO of Tekelec, a telecommunications software company, from Feb 06 – Jan 11. At Tekelec, he led the company’s efforts to grow outside of its traditional US based business. Under his leadership, the company secured business in all four of the BRIC (Brazil, Russia, India, China) countries as well as over 40 additional countries. These efforts led to Tekelec being named one of the Top 200 Small Businesses by Forbes in both 2008 and 2009. Tekelec was also named Public Company of the Year by NCTA in 2009. Frank has complimented this operating experience with roles at Warburg Pincus, a leading New York based private equity firm, and the Toronto office of PWC. In 2006, he was named one of the 50 Most Powerful People in NC Business by Business Leader magazine. He has also been featured in articles in Forbes, The Wall Street Journal, The Times of India, France’s Le Figaro, Canada’s National Post and the Globe and Mail and Raleigh’s TBJ and News & Observer.

Frank currently serves on the Board of Cree (Nasdaq:CREE). Past public company and private company Board experience includes FirstNet, Tekelec, Proxim, Presidio, Baanto, Petroliance, BTI, Pinpoint/Motricity, Ronald McDonald House of Durham, First Flight Ventures Corp, Duke Heart Center and Duke Fuqua School of Business, NC Symphony, NCTA, MCNC and the Wake County Boys and Girls Club Boards.

Frank is a native of Toronto, Canada, and a graduate of the University of Toronto. He is now a US citizen and has resided in North Carolina since 1997.

More